NCI/X
Jan 1, 2025, 07:50
CCR Year-end Roundup: NCI’s Most Viewed Science Stories of 2024
NCI Center for Cancer Research shared on LinkedIn:
“CCR Year-end Roundup: Our Most Viewed Science Stories of 2024
A team of researchers led by Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology and Principal Deputy Director of the National Cancer Institute, uncovered a surprising discovery about one of the most rigorously studied oncoproteins in human cancer. It may be possible to exploit this previously unrecognized role of RAS to develop combination therapies that boost the anti-cancer effects of RAS-inhibiting drugs.
Read the NCI press release.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 12:51
Aug 6, 2025, 12:09
Aug 6, 2025, 11:45
Aug 6, 2025, 09:33
Aug 6, 2025, 09:22